| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
0.49 |
Evidence |
|
| CFTR |
CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
0.49 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
0.49 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
0.49 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
0.49 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
0.49 |
Evidence |
|
| KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
0.49 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
IGF2R |
IGF2R, MPRI: Cation-independent mannose-6-phosphate receptor precursor |
0.49 |
Evidence |
|
| WASPIP |
IPI00552369 |
MMP13 |
MMP13: Collagenase 3 precursor |
0.49 |
Evidence |
|
| TUBG1 |
TUBG1, TUBG: Tubulin gamma-1 chain |
YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
0.487 |
Evidence |
|
| ARF1 |
ARF1: ADP-ribosylation factor 1 |
ARFGEF1 |
ARFGEF1, ARFGEP1, BIG1: Brefeldin A-inhibited guanine nucleotide-exchange protei |
0.487 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
TSG101 |
TSG101: Tumor susceptibility gene 101 protein |
0.487 |
Evidence |
|
| PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
RELB |
RELB: Transcription factor RelB |
0.487 |
Evidence |
|
| SLC9A3 |
SLC9A3, NHE3: Sodium/hydrogen exchanger 3 |
GRAP |
GRAP: GRB2-related adapter protein |
0.487 |
Evidence |
|
| CCND2 |
CCND2: G1/S-specific cyclin-D2 |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
0.487 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
KHDRBS3 |
KHDRBS3, SALP, SLM2: KH domain-containing, RNA-binding, signal transduction-asso |
0.487 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
STX12 |
STX12: Syntaxin-12 |
0.487 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
STX3A |
STX3, STX3A: Syntaxin-3 |
0.487 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
TAF12 |
TAF12, TAF15, TAF2J, TAFII20: Transcription initiation factor TFIID subunit 12 |
0.487 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
CDON |
CDON, CDO: Cell adhesion molecule-related/down-regulated by oncogenes precursor |
0.487 |
Evidence |
|
| STX11 |
STX11: Syntaxin-11 |
CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
0.487 |
Evidence |
|
| KPNA5 |
KPNA5: Importin subunit alpha-6 |
HIST1H2BG |
HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2B |
0.487 |
Evidence |
|
| LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
MPZL1 |
MPZL1, PZR, UNQ849/PRO1787: Myelin protein zero-like protein 1 precursor |
0.485 |
Evidence |
|
| CRLF3 |
IPI00295387 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.485 |
Evidence |
|
| COL5A2 |
IPI00293881 |
MPZL1 |
MPZL1, PZR, UNQ849/PRO1787: Myelin protein zero-like protein 1 precursor |
0.485 |
Evidence |
|